Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

12.16
Delayed Data
As of Feb 27
 +0.23 / +1.93%
Today’s Change
10.85
Today|||52-Week Range
18.48
-14.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-28.1M-22.7M-46.7M--
 
 
 
 
Depreciation47.0K35.0K54.0K--
 
 
 
 
Total Other Cash Flow1.8M2.2M5.9M--
 
 
 
 
Funds From Operations-26.2M-20.5M-40.8M--
 
 
 
 
Extraordinary Items0.00-2.6M----
 
 
Funds From/For Other Operating Expenses-3.4M1.6M-6.5M--
 
 
 
 
Net Cash Flow - Operating Activities-22.8M-24.8M-34.3M--
 
 
 
 
 
InvestingIncrease In Investments-9.9M-11.3M-24.4M--
 
 
 
 
Decrease In Investments5.8M15.5M24.4M--
 
 
 
 
Capital Expenditures-57.0K-24.0K-346.0K--
 
 
 
 
Net Cash Flow Investing-4.2M4.2M-346.0K--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale33.8M0.0075.7M--
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing33.8M0.0075.7M--
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash6.8M-20.6M41.0M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account